Only when these traits become extreme, maladaptive, and cause clinically significant impairment in several aspects of ones life should a diagnosis of OCPD be considered. Personality change due to another medical condition. Obsessive–compulsive personality disorder must be differentiated from a personality change due to a medical condition, which affects the central nervous system, and may cause changes in behavior and traits. Substance use disorders. Substance use may cause the advent of obsessive-compulsive traits. It is necessary that this is distinguished from underlying and persistent behavior, which must occur when a person is not under influence of a substance. ICD-10
The World Health Organizations ICD-10 uses the term anankastic personality disorder (F60.5). At least four of the following must be present:

Feelings of doubt
Perfectionism
Excessive conscientiousness
Checking and preoccupation with details
Stubbornness
Caution
Rigidity
Insistent and unwelcome thoughts or impulses that do not attain the severity of an obsessive-compulsive disorder. Millons subtypes
In his book, Personality Disorders in Modern Life, Theodore Millon describes 5 types of obsessive–compulsive personality disorder, which he shortened to compulsive personality disorder. Comorbidity
Obsessive–compulsive disorder
OCPD is often confused with obsessive-compulsive disorder (OCD). Despite the similar names, they are two distinct disorders. Some OCPD individuals do have OCD, and the two can be found in the same family, sometimes along with eating disorders.The rate of comorbidity of OCPD in patients with OCD is estimated to be around 15–28%.
Oxazepam is a short-to-intermediate-acting benzodiazepine. Oxazepam is used for the treatment of anxiety and insomnia and in the control of symptoms of alcohol withdrawal syndrome. It is a metabolite of diazepam, prazepam, and temazepam, and has moderate amnesic, anxiolytic, anticonvulsant, hypnotic, sedative, and skeletal muscle relaxant properties compared to other benzodiazepines.It was patented in 1962 and approved for medical use in 1964. Medical uses
It is an intermediate-acting benzodiazepine with a slow onset of action, so it is usually prescribed to individuals who have trouble staying asleep, rather than falling asleep. It is commonly prescribed for anxiety disorders with associated tension, irritability, and agitation. It is also prescribed for drug and alcohol withdrawal, and for anxiety associated with depression. Physicians may use oxazepam outside its approved indications to treat social phobia, post-traumatic stress disorder, insomnia, premenstrual syndrome, and other conditions. Side effects
The side effects of oxazepam are similar to those of other benzodiazepines, and may include dizziness, drowsiness, headache, memory impairment, paradoxical excitement, and anterograde amnesia, but does not affect transient global amnesia. Side effects due to rapid decrease in dose or abrupt withdrawal from oxazepam may include abdominal and muscle cramps, convulsions, depression, inability to fall asleep or stay asleep, sweating, tremors, or vomiting.In September 2020, the U.S. Food and Drug Administration (FDA) required the boxed warning be updated for all benzodiazepine medicines to describe the risks of abuse, misuse, addiction, physical dependence, and withdrawal reactions consistently across all the medicines in the class.